Trial of Chinese Prescription on Ulcerative Colitis
Not Applicable
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: bascial prescription plus or minus herbs depend on symptoms
- Registration Number
- NCT00963287
- Lead Sponsor
- Shanghai University of Traditional Chinese Medicine
- Brief Summary
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Clinical diagnosis of ulcerative colitis
- Male of female patients between 18-65 years old
- Written informed consent
Exclusion Criteria
- Combine with malignant pathology on epithelial dysplasia of mucosa
- Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
- Pregnancy or breast feeding women, or unwilling to have contraception.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description bascial prescription bascial prescription plus or minus herbs depend on symptoms Decoction ,two times a day,one bag of decoction one time low does of bascial decoction bascial prescription plus or minus herbs depend on symptoms Decoction ,two times a day, one bag decoction of one time
- Primary Outcome Measures
Name Time Method Histopathological examination,enteroscopy,blood test,symptoms ,pulse tracings,tongue demonstration 8 weeks
- Secondary Outcome Measures
Name Time Method Indicates of liver and renal function 8 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of Chinese herbal prescriptions in treating Ulcerative Colitis?
How does the Chinese prescription in NCT00963287 compare to 5-aminosalicylates and corticosteroids in UC treatment outcomes?
Are there specific biomarkers associated with response to Chinese herbal therapies in Ulcerative Colitis patients?
What adverse events are reported with Chinese prescriptions for UC and how are they managed clinically?
What combination therapies involving Chinese herbs show promise in managing refractory Ulcerative Colitis?
Trial Locations
- Locations (1)
Longhua hospital
🇨🇳Shanghai, Shanghai, China
Longhua hospital🇨🇳Shanghai, Shanghai, China